@Samuel, is this BACME quote from the stakeholders comments? Many thanks.
hi anniekim, the [to me potentially suspicious] quote in
https://www.s4me.info/posts/386588/ should be in bacme's press statement yesterday [via tom kindlon, public].
===
From: Dr. Marc-Alexander Fluks
Source: British Association for ME/CFS (BACME)
Date : October 29, 2021
URL:
https://www.bacme.info/sites/bacme....ement NICE Guideline publication Oct 2021.pdf
The new NICE Guideline on ME/CFS was published on 29th October 2021
This is BACME's response to the publication:
-------------------------------------------------------------------
BACME welcomes the new NICE Guidance on ME/CFS in the hope that this
will support continued progress in improving the quality of life of all
people who have the complex illness ME/CFS.
Clinicians working in NHS specialist ME/CFS services strive to provide
high quality care and support to people with ME/CFS while recognising
that there is still a long way to go with our understanding of the
condition and we do not yet have a robust evidence base on which to
guide treatments and therapy approaches.
The new NICE guideline provides information regarding diagnosis
including the importance of recognising the key symptom of
Post-Exertional Malaise. The guideline has also clarified the use of the
term Graded Exercise Therapy (GET) and,in a change from the previous
guideline, it has now restricted use of the term GET todescribe therapy
programmes based on treating deconditioning. The symptoms of ME/CFS are
not caused by deconditioning. This guideline marks the move away from
using GET programmes for treating ME/CFS. This is a move the majority of
BACME members working in NHS specialist services have already made.
BACME welcomes the fact the new NICE guideline specifies that clinicians
from all disciplines delivering care to people with ME/CFS should have
specialist knowledge of the condition.
BACME continues to support research which aims to provide further
understanding of the underlying pathological processes that generate the
symptoms experienced by people with ME/CFS in the hope this will also
lead to more refined therapeutic approaches.
BACME recognises the importance of providing confident support to people
with ME/CFS now and would like to see increased investment in specialist
service provision to ensure equitable access for all people with ME/CFS.
BACME will use the new NICE guideline as a foundation on which to build
further clinical guidance on the delivery of care to people with ME/CFS
and work to ensure that the patient story is heard and embedded in the
future of ME/CFS care.
--------
(c) 2021 BACME
===